Anti-Lipoteichoic acid [BSYX-A110 (Pagibaximab)]

Description:

Recombinant monoclonal antibody to Lipoteichoic acid. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma BSYX-A110 (Pagibaximab).

Clone Name:
BSYX-A110 (Pagibaximab)
Published Application(s):
therapeutic, ELISA
Published Species Reactivity:
Gram Positive Bacteria
5
Products based on this clone:
  • {{heading}}
Please Select
  • Ab02032-10.0 Anti-Lipoteichoic acid [BSYX-A110 (Pagibaximab)]
  • Gram Positive Bacteria
  • Human IgG1
  • Purified
  • Ships in 4-5 weeks
  • Ab02032-10.3 Anti-Lipoteichoic acid [BSYX-A110 (Pagibaximab)]
  • Gram Positive Bacteria
  • Human IgG1
  • Fc Silent™
  • Purified
  • In Stock
  • Ab02032-1.1 Anti-Lipoteichoic acid [BSYX-A110 (Pagibaximab)]
  • Gram Positive Bacteria
  • Mouse IgG1
  • Purified
  • In Stock
  • Ab02032-1.4 Anti-Lipoteichoic acid [BSYX-A110 (Pagibaximab)]
  • Gram Positive Bacteria
  • Mouse IgG1
  • Fc Silent™
  • Purified
  • Ships in 4-5 weeks
  • Ab02032-23.0 Anti-Lipoteichoic acid [BSYX-A110 (Pagibaximab)]
  • Gram Positive Bacteria
  • Rabbit IgG
  • Purified
  • Ships in 4-5 weeks
Loading...